Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

GlaxoSmithKline Gets $94M Contract for Antibiotic

By Pharmaceutical Processing | September 7, 2011

British drugmaker GlaxoSmithKline PLC will receive up to $94 million from the U.S. Department of Health and Human Services to support research and clinical testing for an antibiotic discovered by Anacor Pharmaceuticals Inc.

The money will help evaluate the antibiotic, labeled GSK ‘052, against bioterrorism threats. It also will fund a mid-stage trial for ventilator-associated pneumonia and a late-stage study for complicated intra-abdominal infections, according to Palo Alto, Calif.-based Anacor. The funding for up to four years comes from the department’s Biomedical Advanced Research and Development Authority.

GSK ‘052 targets a bacterial enzyme needed for protein synthesis. Anacor licensed the compound to Glaxo last year and received an option exercise fee of $15 million. It also is eligible for future development milestone payments of up to $75.5 million and commercial milestone payments of up to $175 million as well as royalty payments. Glaxo is responsible for development and commercialization of GSK ‘052.

Glaxo’s U.S. shares rose 14 cents to $41.69 in premarket trading.

 

 

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE